Effects of a <i>Ganoderma lucidum</i> Proteoglycan on Type 2 Diabetic Rats and the Recovery of Rat Pancreatic Islets
Fanzhen Yu, Yilong Teng, Jiaqi Li, Shutong Yang, Zeng Zhang, Yanming He, Hongjie Yang, Chuan‐Fan Ding, Ping Zhou
Abstract
High Resolution Image Download MS PowerPoint Slide Type 2 diabetes (T2D) results from both insulin resistance and pancreatic β-cell dysfunction. A natural proteoglycan extracted from Ganoderma lucidum, namely, FYGL, has been demonstrated to be capable of ameliorating insulin resistance in previous work. In this work, a T2D rat model induced by streptozocin (STZ) and a high-fat diet was used to investigate the effects of FYGL on pancreatic functions, and the transcriptomics of the rat pancreas was used to investigate the biological processes (BP) and signal pathways influenced by FYGL on the gene basis. Furthermore, the results of transcriptomics were verified both by histopathological analyses and protein expression. The studies showed that FYGL positively regulated T2D-related BP and signaling pathways and recovered the pancreatic function, therefore ameliorating hyperglycemia and hyperlipidemia in vivo . Importantly, the recovery of the pancreatic function suggested a crucial strategy to radically treat T2D.